The Pan American Network for Drug Regulatory Harmonization (PANDRH) is an initiative of the national regulatory authorities within the Region, and PAHO, that supports the processes of pharmaceutical regulatory harmonization in the Americas, within the framework of national and sub-regional health policies and recognizing pre-existing asymmetries.
The Components of PANDRH are: The Pan American Conference on Drug Regulatory Harmonization (PANDHR), the Steering Committee (SC), the Technical Working Groups (WGs) in the areas considered as priority by the Conference, and the Secretariat.
PANDRH´s Norms, regulations, members, and the Steering Committee
This section describes the goals, objectives, functions, components of the PANDRH and its Secretariat.
Report from the Secretariat 1997 - 2005. Pan American Network for Drug Regulatory Harmonization. An Overview.
- Introduction and background
- The World Health Organization and Harmonization of Drug Regulation
- Pan American Conferences for Drug Regulatory Harmonization (PANDRH)
- The Pan American Network for Drug Regulatory Harmonization (PANDRH)
- PANDRH’ Operational Process
- PANDRH Working Groups
- Others Working Groups and Projects
- Finance of PANDRH
- Advantages PANDRH
- Final comment
Pan American Conferences for Drug Regulatory Harmonization
These conferences constitute a continental forum that deals with the drug regulatory harmonization. It includes the presence of all the region’s drug regulatory authorities, as well as representation of organisms for economic integration such as CARICOM, MERCOSUR, TLCA, Latin American Association for Integration (ALADI) and the Andean Community; Academics; representation of regional professional association; and other groups interested from all the continent sub-regions.
The conference constitutes a way to disseminate the decisions on drug regulatory harmonization of global initiatives, such as the International Conference of Drug Regulatory Authorities (ICDRA) and the International Conference on Harmonization (ICH). The PANDRG has become member of the Global Cooperation Group of the ICH.
The Conference also facilitates the integration of the countries from the continent that do not belong to the sub-region blocks, as is the case of Cuba, Dominican Republic and Chile. Its main objective is to support the harmonization processes through the analysis of specific aspect and the adoption of recommendations on priority subjects and harmonized guidelines proposed by the working groups established by the conference itself. Conclusion and recommendations Conference are expected to used by the economic integration groups in its harmonization processes and by all drug regulatory authorities in the countries of the region.
Conference´s Minutes and Conclusions:
Regional Office for the Americas of the World Health Organization